Uploaded October 2026 | Updated November 2026, 17 hours ago
Daniela Rogoff, MD, PhD, Chief Medical Officer, Skeletal Dysplasia of BridgeBio, discusses the efficacy of infigratinib to treat persons with achondroplasia.
To view the full interview, visit checkrare.com/efficacy-of-infigratinib-on-achondroplasia
Daniela Rogoff, MD, PhD, Chief Medical Officer, Skeletal Dysplasia of BridgeBio, discusses the efficacy of infigratinib to treat persons with achondroplasia.
To view the full interview, visit checkrare.com/efficacy-of-infigratinib-on-achondroplasia










